Clinical Trial Update: Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

View source ↗

Summary

A study at Loma Linda University is evaluating biomarkers across different types of amyotrophic lateral sclerosis in patients treated with edaravone, and the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Radicava (edaravone)

Snippet

Sponsor: Loma Linda University | Conditions: Amyotrophic Lateral Sclerosis | Status: RECRUITING